PortfoliosLab logoPortfoliosLab logo
USNA vs. TRMD
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

USNA vs. TRMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in USANA Health Sciences, Inc. (USNA) and TORM plc (TRMD). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, USNA achieves a -11.05% return, which is significantly lower than TRMD's 51.10% return.


USNA

1D
-3.27%
1M
-5.93%
YTD
-11.05%
6M
-13.61%
1Y
-41.51%
3Y*
-34.99%
5Y*
-30.17%
10Y*
-11.93%

TRMD

1D
0.11%
1M
-12.81%
YTD
51.10%
6M
38.71%
1Y
87.62%
3Y*
18.91%
5Y*
42.68%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

USNA vs. TRMD - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
USNA
USANA Health Sciences, Inc.
-11.05%-45.31%-33.04%0.75%-47.43%31.26%-1.85%-33.28%52.11%
TRMD
TORM plc
51.10%11.21%-23.37%31.64%297.66%12.91%-25.94%84.18%-22.59%

Correlation

The correlation between USNA and TRMD is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.04

Correlation (5Y)
Calculated over the trailing 5-year period

0.05

Correlation (All Time)
Calculated using the full available price history since Feb 26, 2018

0.04

Fundamentals

Market Cap

USNA:

$321.46M

TRMD:

$2.91B

EPS

USNA:

$0.48

TRMD:

$3.40

PE Ratio

USNA:

36.18

TRMD:

8.28

PS Ratio

USNA:

0.35

TRMD:

2.02

PB Ratio

USNA:

0.59

TRMD:

1.28

Total Revenue (TTM)

USNA:

$925.94M

TRMD:

$1.41B

Gross Profit (TTM)

USNA:

$726.43M

TRMD:

$575.03M

EBITDA (TTM)

USNA:

$81.50M

TRMD:

$639.99M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

USNA vs. TRMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

USNA
USNA Risk / Return Rank: 1010
Overall Rank
USNA Sharpe Ratio Rank: 77
Sharpe Ratio Rank
USNA Sortino Ratio Rank: 99
Sortino Ratio Rank
USNA Omega Ratio Rank: 88
Omega Ratio Rank
USNA Calmar Ratio Rank: 1111
Calmar Ratio Rank
USNA Martin Ratio Rank: 1717
Martin Ratio Rank

TRMD
TRMD Risk / Return Rank: 8888
Overall Rank
TRMD Sharpe Ratio Rank: 9090
Sharpe Ratio Rank
TRMD Sortino Ratio Rank: 8787
Sortino Ratio Rank
TRMD Omega Ratio Rank: 8383
Omega Ratio Rank
TRMD Calmar Ratio Rank: 8989
Calmar Ratio Rank
TRMD Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

USNA vs. TRMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for USANA Health Sciences, Inc. (USNA) and TORM plc (TRMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


USNATRMDDifference

Sharpe ratio

Return per unit of total volatility

-0.90

2.32

-3.21

Sortino ratio

Return per unit of downside risk

-1.16

2.91

-4.07

Omega ratio

Gain probability vs. loss probability

0.84

1.35

-0.51

Calmar ratio

Return relative to maximum drawdown

-0.80

4.39

-5.19

Martin ratio

Return relative to average drawdown

-1.13

11.44

-12.56

USNA vs. TRMD - Sharpe Ratio Comparison

The current USNA Sharpe Ratio is -0.90, which is lower than the TRMD Sharpe Ratio of 2.32. The chart below compares the historical Sharpe Ratios of USNA and TRMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


USNATRMDDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.90

2.32

-3.21

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.84

0.93

-1.77

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.31

Sharpe Ratio (All Time)

Calculated using the full available price history

0.10

0.48

-0.38

Drawdowns

USNA vs. TRMD - Drawdown Comparison

The maximum USNA drawdown since its inception was -94.90%, which is greater than TRMD's maximum drawdown of -60.59%. Use the drawdown chart below to compare losses from any high point for USNA and TRMD.


Loading charts...

Drawdown Indicators


USNATRMDDifference

Max Drawdown

Largest peak-to-trough decline

-94.90%

-60.59%

-34.31%

Max Drawdown (1Y)

Largest decline over 1 year

-52.30%

-20.06%

-32.24%

Max Drawdown (3Y)

Largest decline over 3 years

-75.12%

-60.59%

-14.53%

Max Drawdown (5Y)

Largest decline over 5 years

-83.92%

-60.59%

-23.33%

Max Drawdown (10Y)

Largest decline over 10 years

-87.60%

Current Drawdown

Current decline from peak

-87.19%

-17.33%

-69.86%

Average Drawdown

Average peak-to-trough decline

-41.01%

-22.58%

-18.43%

Ulcer Index

Depth and duration of drawdowns from previous peaks

36.91%

7.69%

+29.22%

Volatility

USNA vs. TRMD - Volatility Comparison

USANA Health Sciences, Inc. (USNA) and TORM plc (TRMD) have volatilities of 13.97% and 14.52%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


USNATRMDDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.97%

14.52%

-0.55%

Volatility (6M)

Calculated over the trailing 6-month period

29.75%

27.84%

+1.91%

Volatility (1Y)

Calculated over the trailing 1-year period

46.49%

38.07%

+8.42%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

36.09%

46.00%

-9.91%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

38.55%

59.90%

-21.35%

Dividends

USNA vs. TRMD - Dividend Comparison

USNA has not paid dividends to shareholders, while TRMD's dividend yield for the trailing twelve months is around 8.59%.


PositionTTM202520242023202220212020
TRMD
TORM plc
8.59%10.32%30.13%23.05%6.99%0.00%14.89%
USNA
USANA Health Sciences, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Financials

USNA vs. TRMD - Financials Comparison

This section allows you to compare key financial metrics between USANA Health Sciences, Inc. and TORM plc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


100.00M200.00M300.00M400.00M500.00M20222023202420252026
250.22M
395.84M
(USNA) Total Revenue
(TRMD) Total Revenue
Values in USD except per share items

USNA vs. TRMD - Profitability Comparison

The chart below illustrates the profitability comparison between USANA Health Sciences, Inc. and TORM plc over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%90.0%20222023202420252026
76.3%
39.9%
Portfolio components
USNA - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, USANA Health Sciences, Inc. reported a gross profit of 190.78M and revenue of 250.22M. Therefore, the gross margin over that period was 76.3%.

TRMD - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TORM plc reported a gross profit of 157.74M and revenue of 395.84M. Therefore, the gross margin over that period was 39.9%.

USNA - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, USANA Health Sciences, Inc. reported an operating income of 13.87M and revenue of 250.22M, resulting in an operating margin of 5.5%.

TRMD - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TORM plc reported an operating income of 135.10M and revenue of 395.84M, resulting in an operating margin of 34.1%.

USNA - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, USANA Health Sciences, Inc. reported a net income of 7.52M and revenue of 250.22M, resulting in a net margin of 3.0%.

TRMD - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TORM plc reported a net income of 120.52M and revenue of 395.84M, resulting in a net margin of 30.5%.


Frequently Asked Questions


USNA and TRMD have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

TRMD has higher volatility (14.52%) compared to USNA (13.97%). In terms of maximum drawdown, USNA dropped -94.90% vs TRMD's -60.59%.

TRMD currently has the higher Sharpe Ratio (2.32 vs -0.90), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for USNA and TRMD

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer